Pular para o conteúdo principal
Ranking Invest

KRTX - Karuna Therapeutics, Inc.

Segmento: HealthcareKaruna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia; and for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, as well as for the treatment of dementia-related psychosis. The company also focuses on developing other muscarinic-targeted drug candidates. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company, and Zai Lab (Shanghai) Co., Ltd; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics, Inc. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.

Análise Ranking Invest

Valuation estimado
$ 420.72 Mi
Último Balanço Atualizado: 4T2023

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 1.25 Bi

Dívida Líquida

-$ 169.13 Mi

L4T

-$ 422.19 Mi

MM4T

-3290.60%

Indicadores Básicos

ROE

-33.66%

Índices de Previsibilidade

Receita Líquida

G1.46

Lucro

C0.39

Margem

E1.21

Índices de Tendência

Receita Líquida

D2.65

Lucro

G-11.51

Margem

E-3.59

Índices de Endividamento

DIV/PAT

-0.13

DIV/L4T

0.40

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.